Assessing the Value for Money of AI-Assisted Technologies for Older Adults: Scoping Review of Economic Evaluations
Bewertung des Kosten-Nutzen-Verhältnisses von KI-gestützten Technologien für ältere Erwachsene: Scoping Review zu ökonomischen Evaluierungen
Journal of Medical Internet Research · 30.09.2026 · 28 · e104019-e104019
DOI: 10.2196/104019 ↗Auf einen Blick
40 ökonomische Evaluierungen zu KI-gestützten Technologien bei älteren Erwachsenen wurden identifiziert. Viele Berichte fanden Kosteneinsparungen oder Kosteneffektivität, die Aussagekraft war jedoch durch methodische Grenzen eingeschränkt.
Fragestellung
Welche ökonomischen Evaluierungen zu KI-Technologien für ältere Erwachsene liegen vor, und wie verteilen sie sich entlang der ICOPE-Versorgungskette?
Methode
Scoping Review nach PRISMA-ScR; Suche in PubMed, Scopus, Embase, Web of Science und EconLit bis 31. Juli 2026; Bewertung mit CHEQUE.
Ergebnisse
40 Studien aus 2018 bis 2026. 21 berichteten Kosteneinsparungen, 17 Kosteneffektivität. Methodische und Berichtsqualität waren insgesamt hoch; häufig unzureichend berichtet wurden Equity, Subgruppenheterogenität und Modellvalidierung.
Einschränkungen
Equity-Aspekte, Subgruppenheterogenität und Modellvalidierung waren häufig unzureichend berichtet; Aussagen durch modellierte Annahmen und unvollständige Kostenangaben begrenzt.
Schlussfolgerung der Autor:innen
Die Übersichtsarbeit fasst die verfügbare ökonomische Evidenz zu KI-gestützten Technologien in der Versorgung älterer Menschen entlang der ICOPE-Versorgungskette zusammen und zeigt Lücken bei personalisierter Versorgungsplanung und Langzeitmonitoring.
Kernaussagen
- 40 ökonomische Evaluierungen zu KI-Technologien bei älteren Erwachsenen
- 21 Studien mit Kosteneinsparungen, 17 mit Kosteneffektivität
- Evidenzschwerpunkt bei Screening und Diagnostik; wenig zu Langzeitmonitoring
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Scoping Review in der Zeitschrift Journal of Medical Internet Research, online erschienen am 30.09.2026. Verfasst von Qi Gao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, Singapore, 117549,…. Hauptthemen laut MEDLINE: Artificial Intelligence, Cost-Benefit Analysis. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
As populations age globally, AI-enabled digital health interventions (DHIs) are increasingly being adopted to support integrated, person-centered care for older adults. However, despite rapid advances in AI technologies, their economic value in older care remains poorly understood.
Objective
This scoping review aimed to map the existing literature on the economic evaluations of AI technologies for older adults by (1) identifying the types, characteristics, economic outcomes, and methodological approaches reported; (2) mapping the evidence across the World Health Organization’s (WHO) Integrated Care for Older People (ICOPE) pathway; and (3) identifying evidence gaps and priorities for future research.
Methods
A scoping review was conducted following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. PubMed, Scopus, Embase, Web of Science, and EconLit were searched for studies published up to July 31, 2026. Eligible studies were economic evaluations of AI-based technologies in older health care. Conference abstracts, reviews, technical reports, protocols, letters, trial registrations, and non-English studies were excluded. Methodological quality and reporting quality were assessed using the Criteria for Health Economic Quality Evaluation (CHEQUE). Data were synthesized using descriptive statistics and narrative synthesis, with findings mapped to the 4-step ICOPE care pathway.
Results
Forty studies published between 2018 and 2026 met the inclusion criteria. Methodological and reporting quality were generally high (mean scores: 85.7/100 and 85.4/100, respectively), although equity considerations, subgroup heterogeneity, and model validation were frequently underreported. Most evaluations examined AI for screening and diagnosis (32/40), particularly in cancer and ophthalmology, and primarily used model-based approaches, including decision trees, Markov models, and discrete-event simulations. AI-related costs were frequently obtained from assumptions, manufacturer quotes, or expert opinion. Twenty-one of the forty evaluations reported AI interventions to be cost-saving, and another 17 reported AI interventions to be cost-effective. Confidence in these findings is constrained by methodological limitations, reliance on modeled assumptions, and incomplete reporting of AI-related costs. Key drivers of cost-effectiveness included AI performance, AI-related costs, population characteristics, disease burden, and health system context. Along the ICOPE pathway, evidence was concentrated in screening and diagnostic interventions, with little economic evaluation of personalized care planning or long-term monitoring.
Conclusions
This review summarizes the currently available economic evidence on AI-assisted technologies in older health care following the ICOPE care pathway. It extends beyond prior reviews that have assessed AI cost-effectiveness across general or disease-specific populations without addressing the distinct cost structures, care needs, and equity considerations of older adults. By mapping the included evidence against the ICOPE domains, this review identifies where economic evidence is concentrated and where it is critically lacking, providing structured guidance for policy design and future research across different components of the care pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 12 Science Drive 2, Singapore, 117549, Singapore, 65 6516 4988.
- Health Intervention and Technology Assessment Program, Nonthaburi, Thailand.
Zitieren
APA
Gao, Q., Hong, M., Teerawattananon, Y., & Wang, Y. (2026). Assessing the Value for Money of AI-Assisted Technologies for Older Adults: Scoping Review of Economic Evaluations. Journal of Medical Internet Research, 28, e104019-e104019. https://doi.org/10.2196/104019
Vancouver
Gao Q, Hong M, Teerawattananon Y, Wang Y. Assessing the Value for Money of AI-Assisted Technologies for Older Adults: Scoping Review of Economic Evaluations. Journal of Medical Internet Research. 2026;28:e104019-e104019. doi:10.2196/104019
BibTeX
@article{Gao2026,
author = {Gao, Qi and Hong, Minji and Teerawattananon, Yot and Wang, Yi},
title = {Assessing the Value for Money of AI-Assisted Technologies for Older Adults: Scoping Review of Economic Evaluations},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e104019--e104019},
doi = {10.2196/104019}
}
EUVIMED